These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 36002188)

  • 41. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.
    Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J
    Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
    Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
    Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.
    Shen M; Guo L; Zhang H; Zheng B; Liu X; Gu J; Yang T; Sun C; Yi X
    J Nanobiotechnology; 2024 Jun; 22(1):310. PubMed ID: 38831378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
    Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
    Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
    Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.
    Chen Y; Li R; Duan Q; Wu L; Li X; Luo A; Zhang Y; Zhao N; Cui K; Wu W; Liu T; Wan JB; Deng L; Li G; Hou L; Tan W; Xiao Z
    Adv Sci (Weinh); 2024 Aug; 11(32):e2400149. PubMed ID: 38898748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
    Yi M; Niu M; Wu Y; Ge H; Jiao D; Zhu S; Zhang J; Yan Y; Zhou P; Chu Q; Wu K
    J Hematol Oncol; 2022 Oct; 15(1):142. PubMed ID: 36209176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
    Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
    Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single High-Dose Irradiation-Induced iRhom2 Upregulation Promotes Macrophage Antitumor Activity Through cGAS/STING Signaling.
    Zhao X; Wang B; Zhuang Y; Du S; Zeng Z
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1150-1162. PubMed ID: 36792017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
    Wheeler OPG; Unterholzner L
    Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The paradoxical role of radiation-induced cGAS-STING signalling network in tumour immunity.
    Zhang X; Zhang H; Zhang J; Yang M; Zhu M; Yin Y; Fan X; Yu F
    Immunology; 2023 Mar; 168(3):375-388. PubMed ID: 36217274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The Potential of a Novel Therapeutic Strategy for Colorectal Cancer Targeting the cGAS-STING Pathway].
    Nakajima S; Kaneta A; Kono K
    Gan To Kagaku Ryoho; 2023 Sep; 50(9):950-954. PubMed ID: 37800285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
    Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
    Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.